Closing remarks: what future prospects can we expect in migraine management?

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology (2012) 2.96

A new view of pain as a homeostatic emotion. Trends Neurosci (2003) 2.87

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78

Chronic pain may change the structure of the brain. Pain (2008) 2.54

Neurobiology of migraine. Neuroscience (2009) 1.84

Psychiatric comorbidities of episodic and chronic migraine. J Neurol (2012) 1.53

Thickening in the somatosensory cortex of patients with migraine. Neurology (2007) 1.49

Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron (2012) 1.47

Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia (2007) 1.35

Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol (2010) 1.34

Migraine comorbidity constellations. Headache (2007) 1.32

Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med (2006) 1.32

Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci (2009) 1.15

Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations. Headache (2010) 1.12

A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain (2012) 1.11

Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol (2012) 1.07

Clinical course in migraine: conceptualizing migraine transformation. Neurology (2008) 1.06

Pathophysiology of migraine. Neurol Clin (2009) 1.05

Cortical spreading depression-new insights and persistent questions. Cephalalgia (2009) 1.03

Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia (2009) 1.02

Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level dependent in migraine patients and healthy volunteers: pathophysiological implications. Headache (2011) 0.96

Exploring the visual hallucinations of migraine aura: the tacit contribution of illustration. Brain (2007) 0.93

A review of diagnostic and functional imaging in headache. J Headache Pain (2006) 0.92

Emerging target-based paradigms to prevent and treat migraine. Clin Pharmacol Ther (2012) 0.89

Disability in chronic migraine with medication overuse: treatment effects at 3 years. Headache (2007) 0.84

Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations. Neurol Sci (2009) 0.78

Migraine is curable! Neurol Sci (2010) 0.78

Emotional pain without sensory pain--dream on? Neuron (2009) 0.77